Going on a Drug Holiday?

被引：14

作者：

Bonnick, Sydney Lou ^{[1
,2
]}

机构：

[1] Clin Res Ctr N Texas, Denton, TX 76210 USA

[2] Univ N Texas, Dept Kinesiol & Biol Sci, Denton, TX 76203 USA

来源：

JOURNAL OF CLINICAL DENSITOMETRY | 2011年 / 14卷 / 04期

关键词：

FRACTURE INTERVENTION TRIAL; RANDOMIZED CONTROLLED-TRIAL; ZOLEDRONIC ACID; POSTMENOPAUSAL OSTEOPOROSIS; ORAL BISPHOSPHONATES; RISK-FACTORS; AMERICAN-SOCIETY; MINERAL-RESEARCH; DOUBLE-BLIND; TASK-FORCE;

D O I：

10.1016/j.jocd.2011.07.006

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：377 / 383

页数：7

共 33 条

[1]

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors [J].

Bamias, A ;

Kastritis, E ;

Bamia, C ;

Moulopoulos, LA ;

Melakopoulos, L ;

Bozas, G ;

Koutsoukou, V ;

Gika, D ;

Anagnostopoulos, A ;

Papadimitriou, C ;

Terpos, E ;

Dimopoulos, MA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8580-8587

[2]

BARRETTCONNOR E, 2011, OSTEOPOROS IN PRESS

[3]

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [J].

Black, Dennis M. ;

Delmas, Pierre D. ;

Eastell, Richard ;

Reid, Ian R. ;

Boonen, Steven ;

Cauley, Jane A. ;

Cosman, Felicia ;

Lakatos, Peter ;

Leung, Ping Chung ;

Man, Zulema ;

Mautalen, Carlos ;

Mesenbrink, Peter ;

Hu, Huilin ;

Caminis, John ;

Tong, Karen ;

Rosario-Jansen, Theresa ;

Krasnow, Joel ;

Hue, Trisha F. ;

Sellmeyer, Deborah ;

Eriksen, Erik Fink ;

Cummings, Steven R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) :1809-1822

[4]

Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial [J].

Black, Dennis M. ;

Schwartz, Ann V. ;

Ensrud, Kristine E. ;

Cauley, Jane A. ;

Levis, Silvina ;

Quandt, Sara A. ;

Satterfield, Suzanne ;

Wallace, Robert B. ;

Bauer, Douglas C. ;

Palermo, Lisa ;

Wehren, Lois E. ;

Lombardi, Antonio ;

Santora, Arthur C. ;

Cummings, Steven R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24) :2927-2938

[5]

BLACK DM, 1993, OSTEOPOROSIS INT, V3, pS29

[6]

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].

Black, DM ;

Cummings, SR ;

Karpf, DB ;

Cauley, JA ;

Thompson, DE ;

Nevitt, MC ;

Bauer, DC ;

Genant, HK ;

Haskell, WL ;

Marcus, R ;

Ott, SM ;

Torner, JC ;

Quandt, SA ;

Reiss, TF ;

Ensrud, KE .

LANCET, 1996, 348 (9041) :1535-1541

[7]

BLACK DM, 2010, 32 AM SOC BON MIN RE

[8]

Ten years' experience with alendronate for osteoporosis in postmenopausal women [J].

Bone, HG ;

Hosking, D ;

Devogelaer, J ;

Tucci, JR ;

Emkey, RD ;

Tonino, RP ;

Rodriguez-Portales, JA ;

Downs, RW ;

Gupta, J ;

Santora, AC ;

Liberman, UA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1189-1199

[9]

Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women [J].

Boonen, Steven ;

Sellmeyer, Deborah E. ;

Lippuner, Kurt ;

Orlov-Morozov, Alexander ;

Abrams, Ken ;

Mesenbrink, Peter ;

Eriksen, Erik F. ;

Miller, Paul D. .

KIDNEY INTERNATIONAL, 2008, 74 (05) :641-648

[10]

Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer [J].

Cardwell, Chris R. ;

Abnet, Christian C. ;

Cantwell, Marie M. ;

Murray, Liam J. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (06) :657-663

← 1 2 3 4 →